Long Ideas - An announcement this morning from MAP Pharmaceuticals (NASDAQ:MAPP) said that the company will be offering nearly 4 million shares of the company’s common stock at … Continue Reading
Read NowLong Ideas - Idenix Pharmaceuticals (NASDAQ:IDIX) announced Tuesday morning that the company will be restructuring its partnership strategy with Novartis (NYSE:NVS). The announcement nullifies licensing of Tyzeka (IDIX’s … Continue Reading
Read NowLong Ideas - Shares of Horizon Pharmaceuticals (NASDAQ:HZNP) have traded down 25% since the FDA’s approval of Rayos, the company’s delayed-release arthritis drug, last Thursday. As with most … Continue Reading
Read NowLong Ideas - After immense pre-market trading, Dendreon (NASDAQ:DNDN) is down 22% to $4.85 on earnings and news that it will cut 600 jobs and close a New … Continue Reading
Read NowLong Ideas - Amarin Corp. (NASDAQ:AMRN) is trading sharply lower this morning on reports that members of management and the Board sold company stock and exercised options after … Continue Reading
Read NowLong Ideas - This morning, the little-known Omeros Corporation (NASDAQ:OMER) announced that it may have discovered the proteins that activate the alternative pathway of the complement system, an … Continue Reading
Read NowLong Ideas - Belgian drug-maker ThromboGenics NV announced last Friday that it and ex-U.S. partner Novartis (NYSE:NVS) received a nod of approval from an FDA advisory panel investigating … Continue Reading
Read Now